The Two Faces of Reactive Oxygen Species in Cancer

Reactive oxygen species (ROS), now appreciated for their cellular signaling capabilities, have a dual role in cancer. On the one hand, ROS can promote protumorigenic signaling, facilitating cancer cell proliferation, survival, and adaptation to hypoxia. On the other hand, ROS can promote antitumorigenic signaling and trigger oxidative stress–induced cancer cell death. To hyperactivate the cell signaling pathways necessary for cellular transformation and tumorigenesis, cancer cells increase their rate of ROS production compared with normal cells. Concomitantly, in order to maintain ROS homeostasis and evade cell death, cancer cells increase their antioxidant capacity. Compared with normal cells, this altered redox environment of cancer cells may increase their susceptibility to ROS-manipulation therapies. In this review, we discuss the two faces of ROS in cancer, the potential mechanisms underlying ROS signaling, and the opposing cancer therapeutic approaches to targeting ROS.

[1]  Christian M. Metallo,et al.  Reductive carboxylation supports redox homeostasis during anchorage-independent growth , 2016, Nature.

[2]  P. Storz,et al.  Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions. , 2016, Cell reports.

[3]  B. Stockwell,et al.  Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity. , 2016, Cell chemical biology.

[4]  Peng Huang,et al.  Cancer stem cells, metabolism, and therapeutic significance , 2016, Tumor Biology.

[5]  E. Knudsen,et al.  Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities. , 2016, Cell reports.

[6]  C. Martins,et al.  Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities , 2016, Nature.

[7]  P. Puigserver,et al.  Oxidative Dimerization of PHD2 is Responsible for its Inactivation and Contributes to Metabolic Reprogramming via HIF-1α Activation , 2016, Scientific Reports.

[8]  O. Sansom,et al.  Opposing effects of TIGAR- and RAC1-derived ROS on Wnt-driven proliferation in the mouse intestine , 2016, Genes & development.

[9]  Eugenia G. Giannopoulou,et al.  Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH , 2015, Science.

[10]  R. Deberardinis,et al.  NRF2 regulates serine biosynthesis in non-small cell lung cancer , 2015, Nature Genetics.

[11]  M. Bergo,et al.  Antioxidants can increase melanoma metastasis in mice , 2015, Science Translational Medicine.

[12]  D. MacArthur,et al.  A respiratory chain controlled signal transduction cascade in the mitochondrial intermembrane space mediates hydrogen peroxide signaling , 2015, Proceedings of the National Academy of Sciences.

[13]  R. Deberardinis,et al.  Oxidative stress inhibits distant metastasis by human melanoma cells , 2015, Nature.

[14]  H. M. Petrassi,et al.  Suppressors of superoxide production from mitochondrial complex III , 2015, Nature chemical biology.

[15]  Flore Kruiswijk,et al.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill , 2015, Nature Reviews Molecular Cell Biology.

[16]  Kate S. Carroll,et al.  Chemical approaches to discovery and study of sources and targets of hydrogen peroxide redox signaling through NADPH oxidase proteins. , 2015, Annual review of biochemistry.

[17]  N. Chandel,et al.  ROS-dependent signal transduction. , 2015, Current opinion in cell biology.

[18]  D. Sabatini,et al.  SHMT2 drives glioma cell survival in the tumor microenvironment but imposes a dependence on glycine clearance , 2015, Nature.

[19]  W. Gu,et al.  Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.

[20]  F. Gräter,et al.  A proton relay enhances H2O2 sensitivity of GAPDH to facilitate metabolic adaptation. , 2015, Nature chemical biology.

[21]  S. Inoue,et al.  Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. , 2015, Cancer cell.

[22]  S. Ghaffari,et al.  Stem cells and the impact of ROS signaling , 2014, Development.

[23]  M. Brand,et al.  Sites of Superoxide and Hydrogen Peroxide Production by Muscle Mitochondria Assessed ex Vivo under Conditions Mimicking Rest and Exercise* , 2014, The Journal of Biological Chemistry.

[24]  Andrea Glasauer,et al.  Targeting antioxidants for cancer therapy. , 2014, Biochemical pharmacology.

[25]  P. Schumacker,et al.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.

[26]  Zhandong Liu,et al.  Serine catabolism regulates mitochondrial redox control during hypoxia. , 2014, Cancer discovery.

[27]  T. Copetti,et al.  A mitochondrial switch promotes tumor metastasis. , 2014, Cell reports.

[28]  D. Tuveson,et al.  The promise and perils of antioxidants for cancer patients. , 2014, The New England journal of medicine.

[29]  Y. Song,et al.  Targeting Nrf2 Signaling to Combat Chemoresistance , 2014, Journal of cancer prevention.

[30]  T. Finkel,et al.  Cellular mechanisms and physiological consequences of redox-dependent signalling , 2014, Nature Reviews Molecular Cell Biology.

[31]  K. Vousden,et al.  Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. , 2014, Cell Reports.

[32]  N. Chandel,et al.  ROS Function in Redox Signaling and Oxidative Stress , 2014, Current Biology.

[33]  T. Shlomi,et al.  Quantitative flux analysis reveals folate-dependent NADPH production , 2014, Nature.

[34]  Adam M. Feist,et al.  Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. , 2014, Molecular cell.

[35]  V. Gorgoulis,et al.  Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation , 2014, Cell Death and Differentiation.

[36]  J. Sadoshima,et al.  A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation. , 2014, Cell metabolism.

[37]  E. Larsson,et al.  Antioxidants Accelerate Lung Cancer Progression in Mice , 2014, Science Translational Medicine.

[38]  V. Mootha,et al.  Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer , 2014, Nature Communications.

[39]  B. Evans,et al.  SOD2 to SOD1 Switch in Breast Cancer* , 2014, The Journal of Biological Chemistry.

[40]  R. Askeland,et al.  Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis , 2014, Oncogene.

[41]  Andrea Glasauer,et al.  Targeting SOD1 reduces experimental non–small-cell lung cancer. , 2014, The Journal of clinical investigation.

[42]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[43]  Donna D. Zhang,et al.  The emerging role of the Nrf2–Keap1 signaling pathway in cancer , 2013, Genes & development.

[44]  Corbin E. Meacham,et al.  Tumour heterogeneity and cancer cell plasticity , 2013, Nature.

[45]  S. Inoue,et al.  BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival , 2013, The Journal of experimental medicine.

[46]  J. Locasale.  Serine, glycine and one-carbon units: cancer metabolism in full circle , 2013, Nature Reviews Cancer.

[47]  Masayuki Yamamoto,et al.  Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. , 2013, Cancer research.

[48]  Douglas Strathdee,et al.  TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis , 2013, Developmental cell.

[49]  S. Pervaiz,et al.  Redox regulation of cancer cell migration and invasion. , 2013, Mitochondrion.

[50]  M. Kris,et al.  Non-small Cell Lung Cancer , 2013, International Manual of Oncology Practice.

[51]  K. Vousden,et al.  Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death , 2012, Proceedings of the National Academy of Sciences.

[52]  Karen Blyth,et al.  Serine starvation induces stress and p53 dependent metabolic remodeling in cancer cells , 2012, Nature.

[53]  N. Chandel,et al.  Physiological roles of mitochondrial reactive oxygen species. , 2012, Molecular cell.

[54]  Gregory A. Wyant,et al.  Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy , 2012, Proceedings of the National Academy of Sciences.

[55]  In Sup Kil,et al.  Feedback control of adrenal steroidogenesis via H2O2-dependent, reversible inactivation of peroxiredoxin III in mitochondria. , 2012, Molecular cell.

[56]  Navdeep S. Chandel,et al.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.

[57]  G. Semenza,et al.  Hypoxia-Inducible Factors in Physiology and Medicine , 2012, Cell.

[58]  In Sup Kil,et al.  Peroxiredoxin Functions as a Peroxidase and a Regulator and Sensor of Local Peroxides* , 2011, The Journal of Biological Chemistry.

[59]  C. Klaassen,et al.  Beneficial role of Nrf2 in regulating NADPH generation and consumption. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[60]  Chris Sander,et al.  Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines , 2011, Proceedings of the National Academy of Sciences.

[61]  T. Golub,et al.  Selective killing of cancer cells with a small molecule targeting stress response to ROS , 2011, Nature.

[62]  T. Finkel,et al.  Signal transduction by reactive oxygen species , 2011, The Journal of cell biology.

[63]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[64]  A. Subramanian,et al.  Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress , 2011, Proceedings of the National Academy of Sciences.

[65]  P. Pandolfi,et al.  SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. , 2011, Cancer cell.

[66]  M. Ohmura,et al.  CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. , 2011, Cancer cell.

[67]  Nam-Ho Kim,et al.  Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways? , 2011, Journal of signal transduction.

[68]  L. Guarente,et al.  SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production , 2011, Oncogene.

[69]  S. Park,et al.  Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. , 2010, Molecular cell.

[70]  Qinghua Zhou,et al.  Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells , 2010, BMC Cancer.

[71]  W. Wheaton,et al.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.

[72]  D. Sgroi,et al.  Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis , 2010, Proceedings of the National Academy of Sciences.

[73]  Yung-Hyun Choi,et al.  Butein induces G(2)/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. , 2010, Cancer letters.

[74]  Dae-Yeul Yu,et al.  Inactivation of Peroxiredoxin I by Phosphorylation Allows Localized H2O2 Accumulation for Cell Signaling , 2010, Cell.

[75]  C. Deng,et al.  SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. , 2010, Cancer cell.

[76]  R. Guérois,et al.  Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide Formation* , 2010, The Journal of Biological Chemistry.

[77]  L. Lahiry,et al.  Theaflavins retard human breast cancer cell migration by inhibiting NF‐κB via p53‐ROS cross‐talk , 2010, FEBS letters.

[78]  S. Hayward,et al.  Faculty Opinions recommendation of Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. , 2009 .

[79]  A. Levine,et al.  The first 30 years of p53: growing ever more complex , 2009, Nature Reviews Cancer.

[80]  Diana Anderson,et al.  Tks5-Dependent, Nox-Mediated Generation of Reactive Oxygen Species Is Necessary for Invadopodia Formation , 2009, Science Signaling.

[81]  Hanna Y. Irie,et al.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.

[82]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[83]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[84]  Yongqiang Chen,et al.  Superoxide is the major reactive oxygen species regulating autophagy , 2009, Cell Death and Differentiation.

[85]  E. Cesarman,et al.  Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma , 2009, Proceedings of the National Academy of Sciences.

[86]  E. Giannoni,et al.  Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals , 2009, Oncogene.

[87]  K. Schulze-Osthoff,et al.  Switching Akt: from survival signaling to deadly response , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[88]  A. Fisher.  Redox signaling across cell membranes. , 2009, Antioxidants & redox signaling.

[89]  A. Varki,et al.  Molecular basis of metastasis. , 2009, The New England journal of medicine.

[90]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[91]  M. Rincón,et al.  Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival , 2008, International journal of biological sciences.

[92]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[93]  N. Hay,et al.  Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. , 2008, Cancer cell.

[94]  W. Kaelin,et al.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.

[95]  J. Hayashi,et al.  ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.

[96]  J. Margolick,et al.  Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance , 2007, Proceedings of the National Academy of Sciences.

[97]  M. Toledano,et al.  ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis , 2007, Nature Reviews Molecular Cell Biology.

[98]  Jonathan Pevsner,et al.  HIF-dependent antitumorigenic effect of antioxidants in vivo. , 2007, Cancer cell.

[99]  Peiqing Sun,et al.  The pathways to tumor suppression via route p38. , 2007, Trends in biochemical sciences.

[100]  J. Eisenbart,et al.  The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production , 2007, The Journal of cell biology.

[101]  A. Holmgren,et al.  Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. , 2007, American journal of physiology. Heart and circulatory physiology.

[102]  Gabriella De Vita,et al.  p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis , 2007 .

[103]  Jinsong Liu,et al.  Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.

[104]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[105]  B. Viollet,et al.  5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments , 2006, Molecular and Cellular Biology.

[106]  D. Seth,et al.  Redox regulation of MAP kinase phosphatase 3. , 2006, Biochemistry.

[107]  G. Semenza,et al.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.

[108]  F. Domann,et al.  Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose. , 2006, Cancer research.

[109]  P. Chumakov,et al.  The antioxidant function of the p53 tumor suppressor , 2005, Nature Medicine.

[110]  E. Giannoni,et al.  Intracellular Reactive Oxygen Species Activate Src Tyrosine Kinase during Cell Adhesion and Anchorage-Dependent Cell Growth , 2005, Molecular and Cellular Biology.

[111]  F. Muller,et al.  Complex III Releases Superoxide to Both Sides of the Inner Mitochondrial Membrane* , 2004, Journal of Biological Chemistry.

[112]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[113]  U. Ruegg,et al.  Role of superoxide as a signaling molecule. , 2004, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[114]  L. Behrend,et al.  Reactive oxygen species in oncogenic transformation. , 2003, Biochemical Society transactions.

[115]  M. Toledano,et al.  ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin , 2003, Nature.

[116]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[117]  Michael P. Myers,et al.  Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate , 2003, Nature.

[118]  F. Haluska,et al.  PTEN signaling pathways in melanoma , 2003, Oncogene.

[119]  N. Kennedy,et al.  Role of JNK in Tumor Development , 2003, Cell cycle.

[120]  Kap-Seok Yang,et al.  Reversing the Inactivation of Peroxiredoxins Caused by Cysteine Sulfinic Acid Formation , 2003, Science.

[121]  E. Cadenas,et al.  Voltage-dependent Anion Channels Control the Release of the Superoxide Anion from Mitochondria to Cytosol* , 2003, The Journal of Biological Chemistry.

[122]  Ronald A. DePinho,et al.  Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation , 2002, Nature.

[123]  Woojin Jeong,et al.  Reversible Inactivation of the Tumor Suppressor PTEN by H2O2 * , 2002, The Journal of Biological Chemistry.

[124]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[125]  R. Rao,et al.  Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation. , 2002, Biochemical and biophysical research communications.

[126]  C. Ambrosino,et al.  Cell cycle regulation by p38 MAP kinases , 2001, Biology of the cell.

[127]  T Takahashi,et al.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis , 2001, EMBO reports.

[128]  Paul J Thornalley,et al.  Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro. , 2001, Biochemical pharmacology.

[129]  M. Briehl,et al.  Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon. , 2000, Biochemical pharmacology.

[130]  Ken Itoh,et al.  Transcription Factor Nrf2 Coordinately Regulates a Group of Oxidative Stress-inducible Genes in Macrophages* , 2000, The Journal of Biological Chemistry.

[131]  S. Sokol,et al.  Axis determination by inhibition of Wnt signaling in Xenopus. , 1999, Genes & development.

[132]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[133]  H. Hamm,et al.  Molecular Determinants of Selectivity in 5-Hydroxytryptamine1B Receptor-G Protein Interactions* , 1997, The Journal of Biological Chemistry.

[134]  D. Mahvi,et al.  Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan. , 1997, Journal of the National Cancer Institute.

[135]  I. Fridovich.  Superoxide Anion Radical (O·̄2), Superoxide Dismutases, and Related Matters* , 1997, The Journal of Biological Chemistry.

[136]  J. Zweier,et al.  Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts , 1997, Science.

[137]  Minoru Takagi,et al.  Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.

[138]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[139]  V. Ferrans,et al.  Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.

[140]  D. S. St. Clair,et al.  Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. , 1994, Cancer research.

[141]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[142]  C. Nathan,et al.  Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.

[143]  B. Ames,et al.  Oxygen radicals and human disease. , 1987, Annals of internal medicine.

[144]  A. Meister,et al.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). , 1979, The Journal of biological chemistry.

[145]  K. V. Laer.  gapdh to facilitate metabolic adaptation , 2015 .

[146]  Michael J. Oehler,et al.  Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling. , 2015, Nature chemical biology.

[147]  S. Weinberg,et al.  Targeting mitochondria metabolism for cancer therapy. , 2015, Nature chemical biology.

[148]  C. Winterbourn.  The biological chemistry of hydrogen peroxide. , 2013, Methods in enzymology.

[149]  W. D. Martin,et al.  Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+) mice. , 2012, The American journal of pathology.

[150]  J. Chin,et al.  Vitamin E and the risk of prostate cancer: Updated results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[151]  Michael J Morgan,et al.  Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.

[152]  J. Crowley,et al.  Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial ( SELECT ) , 2011 .

[153]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[154]  G. Semenza,et al.  HIF-dependent Anti-tumorigenic Effect of Anti-oxidants In Vivo , 2007 .

[155]  Masayuki Yamamoto,et al.  Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. , 2006, Advances in enzyme regulation.

[156]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[157]  D. S. St. Clair,et al.  Suppression of radiation‐induced neoplastic transformation by overexpression of mitochondrial superoxide dismutase , 1992, Molecular carcinogenesis.